Studied pharmacy with state examination, doctorate as Dr. rer. nat.
Professional career
Since 2014
Independent management consultant
2010 - 2013
Board member for Production and Development
at STADA Arzneimittel AG, Bad Vilbel
1993 - 2010
Advising the Management Board & assumption of
various management positions on a fee basis at
STADA Arzneimittel AG, Bad Vilbel
1985 - 1993
Various positions in the management of STADA
Arzneimittel AG, Bad Vilbel
1980 - 1985
Research assistant at the Chair of Pharmaceuti-
cal Technology at Johannes Gutenberg Univer-
sity in Mainz
Membership of statutory supervisory boards
Since 2020
Chairman of the Advisory Board of the MIP
Pharma Group (Supervisory Board of Mellifera
Sechsunddreißigste
Beteiligungsgesellschaft
Page 1
mbH, Berlin, pursuant to the German Limited Lia-
bility Companies Act (GmbHG))
Since 2019
Member of the Supervisory Board of Mutares
Management SE, Munich (not listed)
Membership of comparable domestic and foreign supervisory bodies of commercial enterprises
None
No other significant activities
Relevant knowledge, skills and experience
Dr. Axel Müller has expertise in the areas of accounting and auditing. In the course of his professional career, Dr. Axel Müller worked for many years at STADA Arzneimittel AG, which was listed on the stock exchange and included in the MDAX at the time, in numerous management positions, in particular in the areas of strategy, M&A and operations, and was most recently responsible for production and development as a member of the Management Board for several years. In this context, he also brings many years of experience in investor relations. After several years as a Senior Advisor at Arthur D. Little, he has been an Associate Partner at Fidelio Healthcare Partners since 2018 and works as an independent management consultant. He therefore brings special knowledge and experience in the application of accounting principles and internal control and risk management systems and has special knowledge and experience in the field of auditing. Dr. Axel Müller regularly undergoes further training in these areas, particularly in the field of ESG and sustainability reporting and auditing.
Disclosures in accordance with the recommendations of the German Corporate Governance Code (GCGC)
In the opinion of the Supervisory Board, Dr. Axel Müller is to be classified as independent. In the opinion of the Supervisory Board, there are no personal or business relationships of Dr. Axel Müller with the Company, its Group companies, the executive bodies of the Company or a shareholder with a material interest in the Company that must be disclosed in accordance with recommendation C.13 GCGC.
Page 2
Attachments
Original Link
Original Document
Permalink
Disclaimer
Mutares SE & Co. KgaA published this content on
23 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
26 April 2024 17:27:57 UTC.
Mutares SE & Co KgaA is a Germany-based holding company focused on acquiring companies in special situations, such as owner or management succession and re-funding. It is active in three segments: Automotive & Mobility, including Elastomer Solutions, a manufacturer of rubber moldings, Plati, a supplier of cable harnesses, Kico, a supplier for automotive technology and STS Group, a supplier for commercial vehicle; Engineering & Technology, including Balcke-Duerr, a producer of power plant components, Donges Group, a manufacturer of bridge and steel constructions, EUPEC, a supplier of coatings for oil and gas pipelines, and Gemini Rail Group, a provider of component and vehicle overhaul services to rolling stock owners, and Goods & Services, including KLANN, a manufacturer of tinplate packaging, Cenpa, a manufacturer of coreboard, La Meusienne, a manufacturer of stainless steel tubes, TrefilUnion, a producer of iron wire and prestressing steel, and keeeper group, a plastic manufacturer.